FOSUN PHARMA (02196) announced that Mr. Liu Yi has been formally elected as an executive director of the 10th Board of Directors during an extraordinary general meeting. His appointment took effect on December 2, 2025, and will last until the end of the current Board's term.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments